PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7883833-13	1995	In summary, DMI increased basal cortisol levels consistent with facilitation of NE neurotransmission and, hence, hypothalamic CRH release.	Desipramine	12-15	corticotropin releasing hormone	Homo sapiens	126-129	
12700702-0	2003	Impact of maternal deprivation on brain corticotropin-releasing hormone circuits: prevention of CRH receptor-2 mRNA changes by desipramine treatment.	Desipramine	127-138	corticotropin releasing hormone	Homo sapiens	40-71	
8464952-0	1993	Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.	Desipramine	10-21	corticotropin releasing hormone	Homo sapiens	63-93	
8464952-1	1993	To assess the effect of desipramine (DMI) on corticotropin-releasing-factor (CRF) activity in the central nervous system, we measured cerebrospinal fluid (CSF) concentrations of CRF in healthy volunteers following short-term administration of DMI or placebo.	Desipramine	37-40	corticotropin releasing hormone	Homo sapiens	45-75	
14735130-6	2004	It was found that imipramine, amitryptyline, desipramine, fluoxetine, and mianserin, present in the culture medium for 5 days, in a concentration-dependent manner inhibited basal hCRH gene promoter activity in undifferentiated Neuro-2A cells, while other drugs under study (citalopram, tianeptine, moclobemide, venlafaxine, reboxetine, mirtazapine, and milnacipram) were inactive.	Desipramine	45-56	corticotropin releasing hormone	Homo sapiens	179-183	
12700702-0	2003	Impact of maternal deprivation on brain corticotropin-releasing hormone circuits: prevention of CRH receptor-2 mRNA changes by desipramine treatment.	Desipramine	127-138	corticotropin releasing hormone	Homo sapiens	96-99